These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3660461)

  • 1. A prospective study of BCG given to young children in Agra, India--a region of high contact with environmental mycobacteria.
    Stanford JL; Cunningham F; Pilkington A; Sargeant I; Series H; Bhatti N; Bennett E; Mehrotra ML
    Tubercle; 1987 Mar; 68(1):39-49. PubMed ID: 3660461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of BCG in Ahmednagar, India.
    Stanford JL; Sheikh N; Bogle G; Baker C; Series H; Mayo P
    Tubercle; 1987 Sep; 68(3):169-76. PubMed ID: 3448795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitisation by mycobacteria and the effects of BCG on children attending schools in the slums of Bombay.
    Stanford JL; Ganapati R; Revankar CR; Lockwood D; Price J; Ashton P; Ashton L; Rees RJ
    Tubercle; 1988 Dec; 69(4):293-8. PubMed ID: 3151532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-vaccination tuberculin sensitivity for assessing BCG vaccination in areas with high prevalence of non-specific sensitivity.
    Narain R; Vallishayee RS; Mayurnath S
    Tubercle; 1981 Dec; 62(4):231-9. PubMed ID: 7336474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity.
    Fine PE; Sterne JA; Pönnighaus JM; Rees RJ
    Lancet; 1994 Nov; 344(8932):1245-9. PubMed ID: 7967984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of positive Mantoux reactions in BCG-vaccinated children.
    al-Kassimi FA; Abdullah AK; al-Orainey IO; Benar AB; al-Hajjaj MS; al-Majed S; al-Wazzan A
    Tubercle; 1991 Jun; 72(2):101-4. PubMed ID: 1949211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
    Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculin conversion and leukocyte migration inhibition test after BCG vaccination in newborn infants.
    Faridi M; Kaur S; Krishnamurthy S; Kumari P
    Hum Vaccin; 2009 Oct; 5(10):690-5. PubMed ID: 19855160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two potential improvements to BCG and their effect on skin test reactivity in the Lebanon.
    Bahr GM; Stanford JL; Rook GA; Rees RJ; Abdelnoor AM; Frayha GJ
    Tubercle; 1986 Sep; 67(3):205-18. PubMed ID: 3535188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The booster effect with repeat tuberculin testing in children and its relationship to BCG vaccination.
    Friedland IR
    S Afr Med J; 1990 Apr; 77(8):387-9. PubMed ID: 2330523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculin reactivity in a population of schoolchildren with high BCG vaccination coverage.
    Bierrenbach AL; Cunha SS; Barreto ML; Pereira SM; Dourado I; Ichihara MY; Brito SC; Rodrigues LC
    Rev Panam Salud Publica; 2003 May; 13(5):285-93. PubMed ID: 12831432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Testing post-vaccination and post-infection hypersensitivity with the use of tuberculin PPD-S BCG Polska. I. Use of tuberculin PPD-S BCG in children vaccinated with BCG vaccine].
    Krzyszkowska A; Rzucidło L; Zelechowska M; Wasowska J; Firko-Stepniewska O; Górski S; Szumilak I
    Pneumonol Pol; 1982 Nov; 50(11):599-607. PubMed ID: 7182815
    [No Abstract]   [Full Text] [Related]  

  • 13. How environmental mycobacteria may predetermine the protective efficacy of BCG.
    Stanford JL; Shield MJ; Rook GA
    Tubercle; 1981 Mar; 62(1):55-62. PubMed ID: 7268920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.
    Black GF; Weir RE; Floyd S; Bliss L; Warndorff DK; Crampin AC; Ngwira B; Sichali L; Nazareth B; Blackwell JM; Branson K; Chaguluka SD; Donovan L; Jarman E; King E; Fine PE; Dockrell HM
    Lancet; 2002 Apr; 359(9315):1393-401. PubMed ID: 11978337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does effect of BCG vaccine decrease with time since vaccination and increase tuberculin skin test reaction?
    Subramani R; Datta M; Swaminathan S
    Indian J Tuberc; 2015 Oct; 62(4):226-9. PubMed ID: 26970464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of Calmette-Guérin bacillus immunization on the booster effect of tuberculin testing in healthy young adults.
    Sepulveda RL; Ferrer X; Latrach C; Sorensen RU
    Am Rev Respir Dis; 1990 Jul; 142(1):24-8. PubMed ID: 2368973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of BCG vaccine on tuberculin skin tests in 7-11-year-old children.
    Bozaykut A; Atay E; Sevim H; Atay Z; Ceran O
    Acta Paediatr; 2004 Aug; 93(8):1033-5. PubMed ID: 15456191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculin conversion in children after BCG vaccination.
    Kebede F
    Ethiop Med J; 1993 Oct; 31(4):265-70. PubMed ID: 8287861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Long-term Effect of Bacille Calmette-Guérin Vaccination on Tuberculin Skin Testing: A 55-Year Follow-Up Study.
    Mancuso JD; Mody RM; Olsen CH; Harrison LH; Santosham M; Aronson NE
    Chest; 2017 Aug; 152(2):282-294. PubMed ID: 28087302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?
    Menzies D
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.